Product

SDR-PEP Rifampicin

1 clinical trial

1 indication

Indication
Leprosy
Clinical trial
Bedaquiline Enhanced Post ExpOsure Prophylaxis for Leprosy: Phase 3 Study
Status: Recruiting, Estimated PCD: 2026-12-31